News
Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
The tech trade is proving resilient, even unstoppable, while the firms that gained by helping people lose weight are ...
The Phillies beat the Baltimore Orioles 5-0 on Tuesday, which pushed them to 65-48 on the season and extended their small ...
20hon MSN
Philadelphia Phillies reliever José Alvarado has rejoined the team following an 80-game suspension for violating baseball's ...
There are some 3853 shows at the Fringe this year. And that’s before you factor in what’s on at the Edinburgh International Festival. How do ...
Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...
19h
Interesting Engineering on MSNOzempic-style obesity drug bypasses neurons, avoids nausea and vomiting side effectsA new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...
Novo Nordisk (NVO) said Wednesday it will cut costs as it faces increasing competition from Eli Lilly (LLY) and generic ...
Shares of Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, fell in pre-market trading and on the ...
NewAmsterdam Pharma Company N.V. (NAMS) delivered earnings and revenue surprises of +71.15% and +486.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead ...
The effects of President Trump’s trade war on households are expected to be a big focus in earnings calls held by major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results